Genomic Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Mol Cell. 2020 May 21;78(4):752-764.e6. doi: 10.1016/j.molcel.2020.03.024. Epub 2020 Apr 24.
Dysregulation of DNA methylation and mRNA alternative cleavage and polyadenylation (APA) are both prevalent in cancer and have been studied as independent processes. We discovered a DNA methylation-regulated APA mechanism when we compared genome-wide DNA methylation and polyadenylation site usage between DNA methylation-competent and DNA methylation-deficient cells. Here, we show that removal of DNA methylation enables CTCF binding and recruitment of the cohesin complex, which, in turn, form chromatin loops that promote proximal polyadenylation site usage. In this DNA demethylated context, either deletion of the CTCF binding site or depletion of RAD21 cohesin complex protein can recover distal polyadenylation site usage. Using data from The Cancer Genome Atlas, we authenticated the relationship between DNA methylation and mRNA polyadenylation isoform expression in vivo. This DNA methylation-regulated APA mechanism demonstrates how aberrant DNA methylation impacts transcriptome diversity and highlights the potential sequelae of global DNA methylation inhibition as a cancer treatment.
DNA 甲基化和 mRNA 可变剪接和多聚腺苷酸化(APA)的失调在癌症中都很普遍,并且已经作为独立的过程进行了研究。当我们比较具有和缺乏 DNA 甲基化能力的细胞之间的全基因组 DNA 甲基化和多聚腺苷酸化位点使用情况时,我们发现了一种 DNA 甲基化调控的 APA 机制。在这里,我们表明,DNA 去甲基化使得 CTCF 结合并募集黏合蛋白复合物,反过来,形成染色质环,促进近端多聚腺苷酸化位点的使用。在这个 DNA 去甲基化的情况下,CTCF 结合位点的缺失或 RAD21 黏合蛋白复合物蛋白的耗竭都可以恢复远端多聚腺苷酸化位点的使用。利用癌症基因组图谱的数据,我们验证了体内 DNA 甲基化与 mRNA 多聚腺苷酸化异构体表达之间的关系。这种 DNA 甲基化调控的 APA 机制展示了异常的 DNA 甲基化如何影响转录组的多样性,并强调了作为癌症治疗的全局 DNA 甲基化抑制的潜在后果。